HMN 2025: How Microfluidic system captures cancer cells with 90% effectivity

Circulating tumor cells (CTCs) consult with cancer cells which have damaged off from a major tumor. These tumor cells can journey by means of the blood within the circulatory system and lodge themselves in different organs to trigger secondary tumors. Therefore, the detection and subsequent characterization of CTCs from blood may help within the medical prognosis and therapy of varied cancers. However, the environment friendly seize of CTCs from blood has been confirmed to be troublesome.

Advancements in micro/nanofabrication applied sciences, together with newer polymer-based supplies, have given rise to microfluidic methods that may detect CTCs. Recent studies point out that by using antibodies as seize molecules, CTCs could be trapped inside the microfluidic methods. But then once more, incorporating antibodies into particular areas inside micro-sized units requires advanced chemical reactions and finally will increase the prices of manufacturing CTC-sensing microdevices on a big scale.

To allow the environment friendly seize of CTCs from blood by way of a cheap sensing platform, a crew of scientists led by Professor Masumi Yamada from the Graduate School of Engineering, Chiba University, Japan, has developed novel microfluidic units that incorporate microcones, comparable in measurement to biological cells. The crew comprised Mr. Yuhei Saito from the Graduate School of Science and Engineering, Chiba University, and Dr. Shuhei Aoyama from Denka Innovation Center, Denka Co., Ltd., Japan. Their analysis findings had been printed within the journal Lab on a Chip on May 28, 2025.

Initially, the researchers utilized polycarbonate (PC) sheets with the microcone arrays with nanometer-sized roughness by using thermal nanoimprint lithography (T-NIL)—a heat-based fabrication expertise. Specifically, T-NIL allowed the preparation of microcones that had been round 30 micrometers in dimensions and packed in a hexagonal sample. Owing to their floor chemistry- and morphology-based interactions, the micro/nanoengineered PC sheet may simply bind to and adsorb antibodies.

To develop a useful microdevice, the scientists coated the fabricated PC sheets with anti-human epithelial cell adhesion molecule antibodies, which may seize cancer cells. The PC sheets had been then sandwiched between a flat plate and a glass slide to type microfluidic channels.

“To examine the affect of the microcone association on the seize behaviors of the cancer cells, we managed the orientation angles of the microcone array within the microgap channels,” says Prof. Yamada.

During experimental evaluation, the microfluidic system demonstrated extremely selective seize of human breast cancer (MCF-7) cells and human lung cancer (A549) cells from the blood samples. Notably, in units where the orientation angles of microcones had been 15° or 30°, the seize effectivity of MCF-7 cells remained greater than 90% even at high move charges. This discovering confirmed that the microcone association was key to the sensing functions of the microfluidic system.

Finally, to spotlight the medical diagnostic functionality of the system, the researchers carried out an immunostaining study utilizing fluorescent dyes to detect particular proteins. Despite utilizing a number of reagents to fluorescently label cells, they discovered that the cancer cells remained trapped inside the micro-channels and didn’t escape. Moreover, throughout commentary underneath fluorescent gentle, the captured cancer cells may very well be simply distinguished from the conventional cells.

Prof. Yamada concludes by describing the potential functions of the novel microcone-containing diagnostic system: “There are many applied sciences for detecting cancer, however it has been a long-standing problem to detect cancer cells with high sensitivity utilizing minimally invasive strategies. We hope that by means of our new microfluidic system, even easy blood exams could be utilized to help within the early prognosis of cancer. It might also be helpful for verifying the effectiveness of cancer therapy and monitoring recurrence after therapy.”

Taken collectively, this study reveals a easy, cost-efficient, and extremely delicate diagnostic instrument to detect circulating cancer cells in blood.